Latest News in the pharma Industry

All

CHMP recommends EU Conditional Marketing Authorisation for Natpar for patients with chronic hypoparathyroidism

CHMP recommends EU Conditional Marketing Authorisation for Natpar for patients with chronic hypoparathyroidism

27 Feb 2017

If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment.

Read more 
Novartis receives positive CHMP opinion for Tafinlar + Mekinist in BRAF-positive NSCLC patients

Novartis receives positive CHMP opinion for Tafinlar + Mekinist in BRAF-positive NSCLC patients

26 Feb 2017

If approved, Tafinlar + Mekinist will be the first targeted therapy specifically for NSCLC patients with a BRAF V600 mutation.

Read more 
Endo Pharmaceuticals recalls one lot of Edex

Endo Pharmaceuticals recalls one lot of Edex

26 Feb 2017

Recall due to potential lack of sterility assurance.

Read more 
Real-world data show lower risk of stroke and major bleeding for Pradaxa compared with warfarin

Real-world data show lower risk of stroke and major bleeding for Pradaxa compared with warfarin

26 Feb 2017

Compared with warfarin, Pradaxa was associated with a 26% reduced risk of stroke and a 20% reduced risk of major bleeding.

Read more 
SGS platform provides modeling and simulation solutions for clinical trials

SGS platform provides modeling and simulation solutions for clinical trials

23 Feb 2017

Tool explores the time course of drug exposure, biomarker response and outcome.

Read more 
Updated Phase I Data show Bavarian Nordic's vaccine candidate induces broad and durable immune response against RSV

Updated Phase I Data show Bavarian Nordic's vaccine candidate induces broad and durable immune response against RSV

23 Feb 2017

Antibody levels maintained against multiple targets 6 months post vaccination.

Read more 
Tillotts Pharma in Germany dedicated to gastrointestinal health

Tillotts Pharma in Germany dedicated to gastrointestinal health

23 Feb 2017

Portfolio includes treatments for Crohn's disease, ulcerative colitis, and bowel preparation before endoscopy.

Read more 
Repatha receives EC approval for new 420 mg single-dose delivery option

Repatha receives EC approval for new 420 mg single-dose delivery option

22 Feb 2017

Approval of the automated mini-doser marks first hands-free administration option for a PCSK9 inhibitor in Europe.

Read more 
NIH begins study of vaccine to protect against mosquito-borne diseases

NIH begins study of vaccine to protect against mosquito-borne diseases

22 Feb 2017

Experimental vaccine targets mosquito saliva.

Read more 
Cell lines and media for difficult to culture tumour types

Cell lines and media for difficult to culture tumour types

22 Feb 2017

Aids R&D initiatives to advance precision medicine.

Read more 
Can yeast rise to the challenge of curing cancer?

Can yeast rise to the challenge of curing cancer?

21 Feb 2017

Modified baker’s yeasts cause an immune response and the production of lymphocyte killers, which detect and eliminate cancerous cells.

Read more 
2016 leaves pharma facing stormy waters

2016 leaves pharma facing stormy waters

21 Feb 2017

EP Vantage Releases its Annual Pharma and Medtech Sector Review Reports for 2016.

Read more